the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Arul Kanda not involved in 1MDB transactions before 2014, court told

KUALA LUMPUR: The High Court today was told that former 1Malaysia Development Berhad (1MDB) president and chief executive officer Arul Kanda Kandasamy was not involved in the alleged wrongful transactions of the company between 2009 and 2014.

United Kingdom-based financial fraud investigator Richard Templeman testified that Arul Kanda, who joined 1MDB in 2015, had no involvement in the transactions related to the first and second bond proceeds used by 1MDB in 2012 for purchasing power plants.

Datuk Shahrol Azral Ibrahim Halmi served as 1MDB CEO from 2009 to 2013, followed briefly by Mohd Hazem Abd Rahman, before Arul Kanda took over from early 2015 until mid-2018.

Arul Kanda’s counsel, Sanjay Mohan questioned Templeman about several specific transactions involving large sums of 1MDB funds, including a US$297,773,000 transfer to an entity owned by fugitive financier Low Taek Jho, also known as Jho Low, Aabar Seychelles, and a US$57 million transfer from Red Granite Capital to Alsen Chance, which occurred before 2014.

Templeman was also asked about a US$11.5 million transfer in 1MDB funds from Affinity, another entity owned by Jho Low, to Red Granite and a US$1.095 billion transfer from an Aabar Investments PJS Ltd account to a Blackstone account.

Sanjay: The Aabar transactions happened between September to November 2014. Correct?

Templeman: Correct.

Sanjay: All these transfers that took place in 2012, had nothing to do with my client, right Mr Templeman?

Templeman: Correct.

Sanjay also argued that some comments made by Templeman in his witness statement contained allegations against his client that were merely speculative and unsubstantiated. The witness disagreed with this assessment.

In May 2021, 1MDB filed a lawsuit against former treasury secretary-general Tan Sri Mohd Irwan Serigar Abdullah and Arul Kanda, alleging breach of trust and conspiracy that resulted in losses of US$1.83 billion related to the company’s investment in 1MDB-Petrosaudi Ltd, which was later converted into the Brazen Sky Limited investment, purportedly recoverable from the Bridge Global Fund.

1MDB also alleged that both defendants committed breach of trust and conspiracy by misappropriating US$3.5 billion in company funds paid to Aabar Investments and US$1.265 billion paid to International Petroleum Investment Company on May 9, 2017.

The company is seeking US$6.59 billion in damages from both defendants for these violations and an additional RM2.9 million from Mohd Irwan related to the extension of his employment agreement.

The trial before Judicial Commissioner Datuk Raja Ahmad Mohzanuddin Shah Raja Mohzan continues tomorrow.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings